| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 |
|---|---|---|---|---|---|---|---|
Revenues | |||||||
7,559 | 7,394 | - | - | - | - | - | - |
Revenues | |||||||
- | - | 5,170 | 2,803 | 823 | 51 | 0 | - |
Cost of revenues | |||||||
4,962 | 5,629 | 3,859 | - | - | - | - | - |
Cost of revenues | |||||||
- | - | - | 3,364 | 1,678 | - | - | - |
Impairment of production line | |||||||
- | - | - | 269 | 0 | - | - | - |
Cost of revenues | |||||||
- | - | - | - | - | 2,274 | 0 | - |
Impairment of production line | |||||||
- | - | - | - | - | 489 | 0 | - |
Gross profit | |||||||
2,597 | 1,765 | 1,311 | -830 | -855 | -2,712 | 0 | - |
Operating expenses: | |||||||
Research and development | |||||||
3,692 | 3,676 | 3,297 | 2,154 | 2,565 | 3,943 | 4,912 | 1,501 |
Sales and marketing | |||||||
11,127 | 10,309 | 7,707 | 4,739 | 1,330 | 1,063 | 2,354 | 295 |
General and administrative | |||||||
5,483 | 5,468 | 4,726 | 3,378 | 2,948 | 3,640 | 6,296 | 2,177 |
Total operating expenses | |||||||
20,302 | 19,453 | 15,730 | 10,271 | 6,843 | 8,646 | 13,562 | - |
Operating loss | |||||||
-17,705 | -17,688 | -14,419 | -11,101 | -7,698 | -11,358 | -13,562 | -3,974 |
Revaluation of warrants | |||||||
0 | -1 | 1,168 | -260 | -571 | -2,194 | 293 | - |
Revaluation of warrants | |||||||
- | - | - | - | - | - | - | -1,606 |
Financial expense, net | |||||||
-31 | -116 | -156 | -46 | -15 | -3,713 | -76 | -105 |
Total financial expenses (income), net | |||||||
-31 | -115 | -1,324 | 214 | 556 | -1,519 | -369 | -1,712 |
Net loss | |||||||
-17,736 | -17,803 | -15,743 | -10,887 | -7,142 | -12,877 | -13,931 | -5,686 |
Deemed dividend | |||||||
-3,155 | -493 | -255 | -710 | - | - | - | - |
Deemed dividend related to May 2015 exchange agreement | |||||||
- | - | - | - | 154 | 0 | - | - |
Deemed dividend related to Series A Preferred Stock exchange agreement | |||||||
- | - | - | - | 0 | 279 | 0 | - |
Deemed dividend related to extension of July 2015 Series A warrants in July 2016 | |||||||
- | - | - | - | 0 | 2,899 | 0 | - |
Net loss attributable to holders of Common Stock | |||||||
-20,891 | -18,296 | -15,998 | -11,607 | -7,296 | -16,055 | -13,931 | - |
Total comprehensive loss | |||||||
- | - | - | - | - | - | - | -5,686 |
Net loss per share: | |||||||
Basic and diluted net loss per share | |||||||
8.00 | 15.63 | 1.64 | 2.09 | 3.84 | 1.85 | 3.80 | 0.46 |
Weighted average number of Common Stock used in computing basic and diluted net loss per share **) | |||||||
2,266 | 1,170 | 9,628 | 5,202 | 1,897 | 8,678 | 3,662 | 12,375 |